CORC  > 山东大学
A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats
Lu, Yu-Yin; Zhao, Cui-Rong; Wang, Rui-Qi; Li, Wen-Bao; Qu, Xian-Jun
刊名BIOMEDICINE & PHARMACOTHERAPY
2015
卷号69页码:255-259
关键词HL-40 Diarylurea derivative Kinases activities Binding constants (K-d) Pharmacokinetics Anti-tumor activities
DOI10.1016/j.biopha.2014.11.003
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4788467
专题山东大学
作者单位1.Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Peoples R China.
2.Shandong Univ, Shandong
推荐引用方式
GB/T 7714
Lu, Yu-Yin,Zhao, Cui-Rong,Wang, Rui-Qi,et al. A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats[J]. BIOMEDICINE & PHARMACOTHERAPY,2015,69:255-259.
APA Lu, Yu-Yin,Zhao, Cui-Rong,Wang, Rui-Qi,Li, Wen-Bao,&Qu, Xian-Jun.(2015).A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats.BIOMEDICINE & PHARMACOTHERAPY,69,255-259.
MLA Lu, Yu-Yin,et al."A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats".BIOMEDICINE & PHARMACOTHERAPY 69(2015):255-259.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace